Activities per year
Activities
- 20 results
Search results
-
Aquired APC-resistance as a marker for VTE, how reliable?
Jonathan Douxfils (Invited speaker)
27 Aug 2023Activity: Talk or presentation types › Invited talk
-
Évaluation du risque vasculaire des contraceptifs
Jonathan Douxfils (Invited speaker)
21 Jun 2023 → 23 Jun 2023Activity: Talk or presentation types › Invited talk
-
Risque induit par les oestrogènes de synthèse en clinique
Jonathan Douxfils (Invited speaker)
8 Jun 2023Activity: Talk or presentation types › Invited talk
-
Estétrol: une nouvelle ère dans la contraception
Jonathan Douxfils (Invited speaker)
11 Feb 2023Activity: Talk or presentation types › Invited talk
-
Thromboembolie veineuse et contraception orale: Quelle stratégie pour minimiser le risque?
Jonathan Douxfils (Invited speaker) & Laure Morimont (Speaker)
12 Jan 2023Activity: Talk or presentation types › Invited talk
-
Hormonal contraception and the risk of venous thrombosis – facts and myths
Jonathan Douxfils (Speaker)
18 Nov 2022Activity: Talk or presentation types › Invited talk
-
Acquired APC resistance as a marker for VTE, how reliable?
Jonathan Douxfils (Speaker)
7 Oct 2022Activity: Talk or presentation types › Invited talk
-
Method validation for haemostasis assays: Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women. An unmet clinical and regulatory need
Jonathan Douxfils (Speaker)
15 Sept 2022Activity: Talk or presentation types › Invited talk
-
Beeak-out Medical: Hemostasis and update on the Post Authorization Safety Study
Jonathan Douxfils (Speaker) & Guillaume Chatel (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
Impact of E4 on hemostasis — Key messages to understand its unique safety profile
Jonathan Douxfils (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
L’associazione Estetrolo/Drospirenone: approfondimento sui parametri ematocoagulativi | Why APC resistance matters?
Jonathan Douxfils (Speaker)
14 Jun 2022Activity: Talk or presentation types › Invited talk
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Jonathan Douxfils (Speaker)
7 Jun 2022Activity: Talk or presentation types › Invited talk
-
Safety profile of E4: recent clinical evidence
Jonathan Douxfils (Speaker)
12 May 2022Activity: Talk or presentation types › Invited talk
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Jonathan Douxfils (Speaker)
17 May 2022Activity: Talk or presentation types › Invited talk
-
Estétrol/drospirénone, le point de vue de l’hém(ost)ato(sio)logue
Jonathan Douxfils (Speaker)
26 Jan 2022Activity: Talk or presentation types › Invited talk
-
Estetrol (E4): Impact on hemostasis
Jonathan Douxfils (Invited speaker)
24 May 2021Activity: Talk or presentation types › Invited talk
-
Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need
Jonathan Douxfils (Invited speaker) & Laure Morimont (Invited speaker)
4 Feb 2021Activity: Talk or presentation types › Invited talk
-
Restoring faith in COC - An important hemostasis update
Jonathan Douxfils (Speaker)
2 Dec 2020Activity: Talk or presentation types › Invited talk
-
Pilule et thrombose : risques et contrôle biologique
Jonathan Douxfils (Speaker)
14 Oct 2019Activity: Talk or presentation types › Invited talk
-
The Namur Thrombosis and Hemostasis Center A gathering of experts from laboratory, clinical and regulatory field
Jonathan Douxfils (Invited speaker)
19 Mar 2019Activity: Talk or presentation types › Invited talk